2012 asipp news header                
American Society of Interventional Pain Physicians News  | September 17, 2014

  IN THIS ISSUE 


  1.  ASIPP Files Petition to Appeal FDA Warning

  2. Physician Payment Schedule: Two Steps Forward, One Step Back - Bundling Issue Continues to Dog CMS and IPM
  3. Hotel Block extended to Sept. 23 for Host October Controlled Substance Workshop in Orlando 
  4. Room block extended to Sept. 23 for the ASIPP Cadaver Workshop and Online Video Lectures Course in October
  5. Consumer Reports Issues Special Report: The dangers of painkillers 
  6. NCHS Issues Data Brief on Drug Poisoning Deaths Involving Opioids 
  7. Some Cancer Experts See 'Overdiagnosis,' Question Emphasis on Early Detection 
  8. Health Law's Election Impact Is Dimming 
  9. Hillary to TCT: Fee-for-Service Days Are Numbered 
  10. AstraZeneca and Nektar win FDA OK for blockbuster-hopeful constipation drug 
appeal

ASIPP Files Petition to Appeal FDA Warning

 

On April 23, 2014 the U.S. Food and Drug Administration (FDA) has issued a warning on injection of corticosteroids into the epidural space. The warning also states that epidurals are not effective.

 

In response, ASIPP has filed an FDA Citizen Petition requesting the Commissioner withdraw the present Safety Warning that States the "FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain and injection of corticosteroids in to the epidural space of the spine may result in rare but serous adverse events, including loss of vision, stroke, paralysis, and death.

 Read the Sept. 3 appeal letter HERE

 

  

As we work to resolve this issue, it is important to discuss the advantages and disadvantages with our patients. Explain to them this is a common off-label use, which we have been doing for some time in our practices.

 

Pain Physician journal Health Policy Opinion: Epidural Steroid Injections Safety Recommendations by the 

Multi-Society Pain Workgroup (MPW): More Regulations Without Evidence or Clarification Click HERE TO READ

 

 

Pain Physician journal  Health Policy Review: Epidural Steroid Warning Controversy Still Dogging FDA Click HERE TO READ

 

Pain Physician journal Letter to the Editor: The Food and Drug Administration's Recent Action on April 23, 2014 Failed to Appropriately Address Safety Concerns about Epidural Steroid Use Click HERE TO READ

 

 

Following is a fact sheet for you to reference. FACT SHEET

 

 

You can also submit comments to FDA on the Regulations.gov Web site:http://www.regulations.gov/#!documentDetail;D=FDA-2013-S-0610-0001

 

 

bundle
Reversal of Epidural Cuts in 2015 Physician Payment Schedule: Two Steps Forward, One Step Back - Bundling Issue Continues to Dog CMS and IPM

 

While the comment period is over for the public, keep in mind there is no deadline for Congress to respond to CMS regarding the proposed 2015 fee schedules. We need to continue our efforts to get the support of our senators and representatives. Below are the comment letters that ASIPP submitted to CMS

.

ASIPP Comment Letter on Physician Payments

 

ASIPP Comment Letter on ASC and HOPD Payments

 

 

We have a meeting scheduled with CMS on September 24 to discuss this. We already have a senate letter signed by additional Senators to join Sen. Roy Blunt (R-MO), Sen. John Boozman (D-AK), and Sen. Mark Pryor (D-AK). There is also a house letter in the works which is already signed by 10 or so members. The house letter will be bipartisan and bicameral.

 

Let's keep the pressure on them by providing as many letters to Congress as possible.


 

Link for  physician letter to Congress - Please place on your letterhead

Capwiz link for Congressional letter from physicians


 

Link for Word version of patient letter  - Please have your patients sign the letter then submit it using the Capwiz link provided.


 

Click here for Capwiz link for patient letter

 

Remember that we still continue to work at very high levels with Congress and the administration to reverse these unfortunate cuts but we need full support and action from our members. We are also hoping that all organizations will unite to fight these disastrous cuts.


 

2015 Proposed Physician Fee Schedule - IPM Codes 

 

You may also send any manuscripts you would like within the next 30 days related to the issue of FDA warning on epidural steroid injections and also on the Multisociety Pain Workgroup 17 recommendations. Following is a link to the statement from ISIS and ASA in which they describe as  response to FDA statement on ESIs, even though FDA will continue the warning with addition of new regulations.

 

Manchikanti L, et al. Epidural steroid warning controversy still dogging FDA. Pain Physician 2014; 17:E451-E474.

 

 

Candido KD, et al. The Food and Drug Administration's Recent Action on April 23, 2014 Failed to Appropriately Address Safety Concerns about Epidural Steroid Use. Pain Physician. 2014 July-August;17(4):E549-E552.

octoberHotel Block extended to Sept. 23 for Host October Controlled Substance Workshop in Orlando


 

The ASIPP Comprehensive Review Course and Competency Exam in Controlled Substance Management and Practice Management Competency Exam will be held in Orlando, Florida, on October 17-19, 2014. Register and reserve your room today to take advantage of ASIPP's room block discount. Hurry and book today. Once this block is filled, the hotel will have no more rooms available.


 

The Controlled Substance Management intensive review course is designed to present interventional pain management specialists and other health care providers an in-depth review of multiple areas of interventional pain management-the areas we were never taught, yet are crucial for our survival.


 
The two-day comprehensive review courses are planned as a CME activity to prepare for competency certification or an in-depth review in areas of What You Need to Know in Controlled Substance Management in IPM. This review course is based on the American Board of Interventional Pain Physicians' specifications for competency certification examinations.

 

This course is intended to present interventional pain management specialists, nurses, and other healthcare providers an in-depth review of multiple areas of interventional pain management including Controlled Substance Management.

Educational Objectives for Controlled Substance Management:

* Review basic science and core concepts

* Discuss pharmacology

* Identify clinical use and effectiveness

* Identify substance abuse

* Discuss topics with documentation, regulatory issues,legal issues, and ethical issues

 

In addition to the review course, the American Board of Interventional Pain Physicians(for physicians) and the American Association of Allied Pain Management Professionals(for non-physicians) offers the opportunity for examination in order for physicians to obtain competency certification to and non-physicians to obtain associate certificates in Controlled Substance Management or Coding, Compliance, and Practice Management.

 

Controlled Substance Management (Oct. 17-18) and Competency Examination (Oct. 19)

Click HERE to register

 

Coding, Compliance, and Practice Management Competency Examination (Oct. 19)

Click HERE to register

 

Brochure

 

ACCOMMODATIONS

ROSEN CENTRE HOTEL

9840 INTERNATIONAL DRIVE, ORLANDO, FL 32819 | (800) 204-7234

 Inform the agent that you are booking for American Society of Interventional Pain Physicians.

We have secured a group room rate of $129. Reserve rooms early-all unbooked rooms will be released after September 23, 2014.

 

Book now
cadaver

Room block extended to Sept. 23 for the ASIPP Cadaver Workshop and Online Video Lectures Course in October

 

 

Hurry and book today. Once this block is filled, the hotel will have no more rooms available.

 

This 1-day workshop is designed for interventional pain physicians, for a review, skills improvement, or to assist in preparation for Comprehensive Interventional Pain Management Examination qualifications. ASIPP offers the most in-depth, comprehensive, and individualized programs available in interventional pain management, featuring maximum hands-on training with cadavers in a state-of-the-art facility and maximum ability to interact with other participants. 

 


 

Participants will experience a comprehensive and intense learning opportunity, focusing on interventional pain management techniques.

  • Each cadaver station is limited to a maximum of 7 participants.
  • Participants can choose the level of participation: basic, intermediate, or ABIPP Preparation
  • C-arms and state-of-the-art equipment are utilized in this course. Participants are requested to dress in casual attire or scrubs. Leaded aprons and thyroid shields will be provided. However, participants are advised to bring their own protective eyewear.
  • Participants will be provided with 7 video lectures relevant to the course material

 

Click HERE to register

 

Brochure

 

 ABIPP Part I Examination- Application 

 

 

ACCOMMODATIONS

ROSEN CENTRE HOTEL

9840 INTERNATIONAL DRIVE, ORLANDO, FL 32819 | (800) 204-7234

 Inform the agent that you are booking for American Society of Interventional Pain Physicians.

We have secured a group room rate of $129. Reserve rooms early-all unbooked rooms will be released after September 23, 2014.

 

Book now

 

consumer
Consumer Reports Issues Special Report: The dangers of painkillers

Every year, Percocet, Vicodin, and other opioids kill 17,000 Americans and acetaminophen sends 80,000 people to the ER

 

America is in pain-and being killed by its painkillers.


 

It starts with drugs such as OxyContin, Percocet, and Vicodin-prescription narcotics that can make days bearable if you are recovering from surgery or suffering from cancer. But they can be as

 

ConsumerReports.Org

 

 

brief

NCHS Issues Data Brief on Drug Poisoning Deaths Involving Opioids

 

 

The National Center for Health Statistics, a division of the US Department  fo Health and Human Services and Centers for Disease Control and Prevention has released a data brief titled Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011

 

Some  Key findings: Data from the National Vital Statistics System, Mortality File

  • The age-adjusted rate for opioid-analgesic poisoning deaths nearly quadrupled from 1.4 per 100,000 in 1999 to 5.4 per 100,000 in 2011.
  • Although the opioid-analgesic poisoning death rates increased each year from 1999 through 2011, the rate of increase has slowed since 2006.
  • Natural and semisynthetic opioid analgesics, such as hydrocodone, morphine, and oxycodone, were involved in 11,693 drug-poisoning deaths in 2011, up from 2,749 deaths in 1999.
  • Benzodiazepines were involved in 31% of the opioid-analgesic poisoning deaths in 2011, up from 13% of the opioid-analgesic poisoning deaths in 1999.
  • During the past decade, adults aged 55-64 and non-Hispanic white persons experienced the greatest increase in the rates of opioid-analgesic poisoning deaths.

 

Center for Disease Control

 

 

cancer
Some Cancer Experts See 'Overdiagnosis,' Question Emphasis on Early Detection

 

Early detection has long been seen as a powerful weapon in the battle against cancer. But some experts now see it as double-edged sword.

 

While it's clear that early-stage cancers are more treatable than late-stage ones, some leading cancer experts say that zealous screening and advanced diagnostic tools are finding ever-smaller abnormalities in prostate, breast, thyroid and other tissues. Many are being labeled cancer or precancer and treated aggressively, even though they may never have caused harm.

 

As a result, these experts say, many people may be undergoing surgery, radiation, chemotherapy and other treatments unnecessarily, sometimes with lifelong side effects.

 

 

Wall Street Journal

 

 

Access to this article may be limited.

impact
Health Law's Election Impact Is Dimming

 

Though Republicans continue to hammer away at the Affordable Care Act, the health-insurance law is losing some of its punch in the 2014 campaign.

 

Polls show that voters don't see the law as a top concern, and both Democrats and Republicans say the election will turn on a range of issues.

 

That outlook is causing both parties to adjust. While some Republicans had billed the election as a referendum on the health law, the GOP is now delivering a broader indictment of what the party describes as the Obama administration's failures. Some Democrats are cautiously stepping out to defend the law, highlighting its most popular provisions while suggesting fixes.

 

 

Wall Street Journal

 

Access to this article may be limited.
hillar
Hillary to TCT: Fee-for-Service Days Are Numbered

 

Hillary Clinton says fee-for-service medicine is probably an idea whose time has passed.


 

"The fee-for-service model, which made a lot of sense for a long time, may not make sense for physicians, for hospitals, or any other providers and may not make sense for patients and other payers," Clinton told a packed house of 3,000 cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) meeting here.


 

Answering a question from TCT president Jack Lewin, MD, she said, "We need to have as evidence-based and mature a conversation as we can have about [fee-for-service]."

 

 

MedPage Today

 

astra

AstraZeneca and Nektar win FDA OK for blockbuster-hopeful constipation drug

 

The FDA approved a new opioid-induced constipation treatment from partners AstraZeneca ($AZN) and Nektar Therapeutics ($NKTR), shaking off some safety concerns and green-lighting a drug the two hope can bring in billions.

The treatment, naloxegol, is an oral blocker of mu-opioid receptors, designed to ease the gastrological side effects associated with common painkillers. In AstraZeneca and Nektar's 1,352-patient pivotal program, the drug proved itself effective in increasing the number of bowel movements among opioid-taking subjects reporting constipation, significantly beating out placebo.


 

But, like other drugs in its class, naloxegol has been linked to an increased risk of heart attacks, and while the agency didn't let that stand in the way of approval, regulators are asking AstraZeneca and Nektar to conduct a large post-market study to keep an eye on any flare-ups in cardiovascular events.

 

 

FierceBiotech

 

 

Hyatt 
     
Join Our Mailing List!
stateState Society News

  

 

INSIPP & KSIPP to Hold Joint Meeting Sept. 20

 

The Indiana and Kentucky Societies of Interventional Pain Physicians will hold its 2014 Annual Meeting September 20, 2014 at the Tropicana Evansville, Evansville, IN

 

Click  HERE for registration form.

 

Click  HERE for brochure.

 

 

Save the Date: NY/NJ Chapters Schedule Pain Medicine Symposium

 

The New York and New Jersey Societies of Interventional Pain Physicians' 2014 Pain Medicine Symposium will be held on November 6 - 9, 2014 at the Hyatt Regency Jersey City in New Jersey.

 

More information will be available soon.

 

 

* Please send your State Society meetings and news to:
 Holly Long at hlong@asipp.org

 

adsPhysicians Wanted

 

If you are interested in advertising on the Physicians Wanted page, please contact Holly Long for pricing information
Phone (270) 554-9412 ext. 230
Fax: (270) 554-5394

hlong@asipp.org

 

Click HERE to view Classified Physicians Wanted Ads listed on the ASIPP website.

ASIPP Members are encouraged to visit and 'Like' or do 'Friend Request' or 'Connect' on ASIPP's new social media sites. ASIPP now has a Facebook account, a Twitter Account, a You Tube account and we are also on LinkedIn. Get more involved today and visit our new sites.
Facebook twitter twitter